INO

Inovio Pharmaceuticals (INO)

About Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Details

Daily high

$5.77

Daily low

$5.38

Price at open

$5.65

52 Week High

$14.75

52 Week Low

$3.89

Market cap

142.5M

Dividend yield

0.00%

Volume

3,606

Avg. volume

371,321

P/E ratio

-1.08

Inovio Pharmaceuticals News